The chaulmoogra fatty acids were empirically known to have some effect against leprosy, but the mechanism was not understood. Modern pharmacological analysis suggests that the cyclopentenyl ring structure of chaulmoogric acid and related compounds may disrupt the lipid metabolism of *M. leprae*, which is an unusual bacterium with a very lipid-rich cell envelope. The bacterium’s thick, waxy coat — which helps it survive inside macrophages and resist many antibiotics — may be susceptible to fatty acids with the specific ring structure that chaulmoogra’s compounds possess. But this mechanistic understanding came much later; in 1915, Ball was working with empirical effectiveness, trying to make a preparation that was deliverable and absorbable, without knowing why the chaulmoogra compounds worked.
—
## The Science of What She Extracted
Extracting the fatty acids from chaulmoogra oil was the first step of Ball’s process, and it required care because the oil contains a complex mixture of compounds. The major fatty acids are chaulmoogric acid and hydnocarpic acid, but the oil also contains gorlic acid and several related compounds from the same chemical family. It also contains the non-active triglyceride forms of these fatty acids — the form in which fatty acids are found in plant oils, bound in threes to a glycerol backbone.
Working with the triglyceride form was one option: the triglycerides could potentially be esterified directly. But the preferable approach for a pharmaceutical preparation was to hydrolyze the triglycerides first — breaking the glycerol backbone and releasing the individual fatty acids — and then work with the free fatty acids. This saponification step (treating the oil with a base to hydrolyze the ester bonds in the triglycerides) was standard chemistry, but performing it selectively on the cyclopentenyl fatty acids while obtaining a clean, consistent product required careful control of reaction conditions.
